Jamie Pierson

Jamie has more than 10 years of experience in the biopharmaceutical industry, primarily in clinical research and technology. She spent her first five years in the industry developing interactive response systems, many of which were for complex cohort and adaptive trials. Jamie’s primary therapeutic area of expertise is neurology, specifically rare pediatric genetic disorders. She has managed rare-disease trials in Duchenne muscular dystrophy, Leigh syndrome, mucopolysaccharidosis, and giant axonal neuropathy.